Ronald Weinstein, MD

Cancer Prevention and Control Program


Weinstein has been a cancer researcher, a pathologist, an educator and an entrepreneur. He was an academic pathology chair for 32 years, in Illinois and Arizona. With a career-long interest in urinary bladder cancer, both as a cancer researcher and as a practicing surgical pathologist, he served as Director of the Central Pathology Laboratory for the National Cancer Institute-funded National Bladder Cancer Program for eight years, providing surgical pathology and cytopathology second opinions for thousands of patients enrolled in national urinary bladder cancer clinical trials.  He invented, patented and commercialized dynamic-robotic telepathology in response to inter-observer variability in surgical pathology diagnosis challenges encountered by the National Bladder Cancer Central Pathology Laboratory in the 1980s. He also successfully lobbied the National Cancer Institute to fund translational research, in the 1980s, and became the Founding Director of the National Cancer Institute-funded National Urinary Bladder Cancer Flow Cytometry Network which brought urine flow cytometry into clinical practice in the 1990s.

Cancer Focus

His basic science research has been on the biology of cancer invasion and metastasis, and on mechanisms of cancer multi-drug resistance.  His clinical research group has studied and implemented a number of innovations in the telemedicine and telehealth arena. They have developed and implemented surgical telepathology services that have been replicated in many countries. His work on bundled telepathology, teleradiology and tele-oncology services is widely cited. More recently, they have focused attentions on smartphone applications in telehealth and on uses of telehealth-based patient training for improving ostomy clinical outcomes.